为临床治愈而奋斗.ppt

* * The data using IFN monotherapy to treat dual infection was very limited. Only sporadic cases had been reported. And frequently, such analysis was retrospective and not primarily focusing on treating patients with dual chronic hepatitis C and B. For example, Mazzella treated 7 pts with primary CH-B, who were later found to be also positive for HCV RNA. He used interferon 5MIU tiw for 6 months for these patients and none lost HCV RNA. From these data, you can see that the HCV RNA clearance rate was very low. This figure shows the End-of-FU HCV SVR rate between dually infected patients and HC